Shanghai Shyndec Pharmaceutical Co., Ltd.

SHSE:600420 Stock Report

Market Cap: CN¥14.1b

Shanghai Shyndec Pharmaceutical Future Growth

Future criteria checks 1/6

Shanghai Shyndec Pharmaceutical is forecast to grow earnings and revenue by 13.8% and 6% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 10.7% in 3 years.

Key information

13.8%

Earnings growth rate

14.0%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate6.0%
Future return on equity10.7%
Analyst coverage

Low

Last updated19 Jul 2024

Recent future growth updates

No updates

Recent updates

Is Shanghai Shyndec Pharmaceutical (SHSE:600420) Using Too Much Debt?

Aug 23
Is Shanghai Shyndec Pharmaceutical (SHSE:600420) Using Too Much Debt?

Improved Earnings Required Before Shanghai Shyndec Pharmaceutical Co., Ltd. (SHSE:600420) Stock's 33% Jump Looks Justified

May 06
Improved Earnings Required Before Shanghai Shyndec Pharmaceutical Co., Ltd. (SHSE:600420) Stock's 33% Jump Looks Justified

Is Shanghai Shyndec Pharmaceutical (SHSE:600420) A Risky Investment?

Apr 30
Is Shanghai Shyndec Pharmaceutical (SHSE:600420) A Risky Investment?

Solid Earnings May Not Tell The Whole Story For Shanghai Shyndec Pharmaceutical (SHSE:600420)

Apr 05
Solid Earnings May Not Tell The Whole Story For Shanghai Shyndec Pharmaceutical (SHSE:600420)

Earnings and Revenue Growth Forecasts

SHSE:600420 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202613,5731,524N/AN/A1
12/31/202512,9271,375N/AN/A1
12/31/202412,3111,206N/AN/A1
6/30/202411,5851,0652,3322,626N/A
3/31/202411,7768441,8802,162N/A
12/31/202312,0706921,3631,720N/A
9/30/202312,4027652,0222,336N/A
6/30/202313,0177482,1862,500N/A
3/31/202313,1327292,4022,708N/A
12/31/202212,9596282,5482,856N/A
9/30/202212,9543631,9242,273N/A
6/30/202212,7003672,1152,503N/A
3/31/202213,2604251,5361,991N/A
12/31/202113,9455681,1581,680N/A
9/30/202113,9036491,1481,712N/A
6/30/202113,9777489661,524N/A
3/31/202113,1827341,4702,002N/A
12/31/202012,5566491,1821,560N/A
9/30/202012,538713153496N/A
6/30/202012,156611-72371N/A
3/31/202012,328607293685N/A
12/31/201912,1996568661,270N/A
9/30/201911,8607032,4182,839N/A
6/30/201911,7236672,3892,779N/A
3/31/201911,3867171,2701,669N/A
12/31/201811,3217061,2701,669N/A
9/30/201810,4166472,2202,530N/A
6/30/20189,7915692,2432,411N/A
3/31/20189,260530N/A2,565N/A
12/31/20178,518516N/A2,315N/A
9/30/20179,086539N/A1,050N/A
6/30/20179,124544N/A869N/A
3/31/20179,324534N/A654N/A
12/31/20169,126477N/A839N/A
9/30/201613,514773N/A1,898N/A
6/30/201612,126697N/A1,821N/A
3/31/201610,388580N/A1,912N/A
12/31/20158,988530N/A1,666N/A
9/30/20152,829206N/A254N/A
6/30/20152,820211N/A50N/A
3/31/20152,882203N/A202N/A
12/31/20142,749190N/A259N/A
9/30/20142,492169N/A292N/A
6/30/20142,442159N/A386N/A
3/31/20142,317137N/A129N/A
12/31/20132,350133N/A207N/A
9/30/20132,481142N/A285N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600420's forecast earnings growth (13.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 600420's earnings (13.8% per year) are forecast to grow slower than the CN market (22.9% per year).

High Growth Earnings: 600420's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600420's revenue (6% per year) is forecast to grow slower than the CN market (13.1% per year).

High Growth Revenue: 600420's revenue (6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600420's Return on Equity is forecast to be low in 3 years time (10.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y